Saeed Soleyman-Jahi



Date of Birth: 8/22/1988; 28 years old


Mobile Phone:+989377793113 


E-mail: [email protected]



Education and Qualifications



  • 2007-14: Medicine, Tehran University of Medical Sciences (GPA: 17.85 out of 20)
  • 2011-13: Master of Public Health, Tehran University of medical sciences (GPA: 17.10 out of 20)



Major Fields of Interest



  • Novel therapeutic, prognostic, and diagnostic modalities in cancer; with more interest in:

    • Gastroenterology cancers
    • Matrix metalloproteinases and other ECM degrading enzymes
    • Immunology and Cancer
    • Cancer Stem-cells
    • mi-RNAs in treatment of cancer
    • Functional imaging in screening, diagnosis and staging of cancer   

  • Clinical studies in Ophthalmology
  • Randomized Clinical Trials and Cohort survival studies
  • Systematic Review and Meta-analysis in cancer
  • Molecular and in-vitro studies in cancer




Publications






Published/In press



  1. Soleyman-JahiS,
    Abdirad A,
    Fallah AA, Ghasemi SSadeghi F,
    Heidari R, Mahmoodzadeh H,
    Zendehdel K.Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: three-year Survival Study.Clin Transl Gastroenterol
    2017 Jan 5;8(1):e209 (Survival study)
  2. Soleyman-Jahi S,
    Nedjat S, Abdirad A, Hoorshad N, Heidari R, Zendehdel K.Prognostic Significance of Matrix Metalloproteinase-7 in Gastric Cancer Survival: a meta-analysis.PloS
    one
    10.4 (2015): e0122316 (Thesis in MD)
  3. Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-Jahi S, Parvaneh
    L, Mahmoudi S, Chavoshzadeh Z, Yazdani R, Zahraei SM, Ebrahimi M, Eslamian MH, Tabatabaie H, Yousefi M, Kandelousi YM, Oujaghlou A, Rezaei N, Aghamohammadi A. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995-2014;   Emerging Infectious Diseases 2016
    Oct;22(10):1712-9. doi: 10.3201/eid2210.151071 (CDC official journal)

  4. Soleyman-Jahi S, Zendehdel K, Abdirad A, Fallah AA, Ghasemi S, Sadeghi F.
    Prognostic significance of plasma ghrelin in patients with gastric cancer.
    Cancer Research 2016; 76(14 Suppl):3412-3412
  5. Mahmoodi M, Soleyman-Jahi S,
    Zendehdel K, Mozdarani H, Azimi C, Farzanfar F, Safari Z, Mohagheghi MA, Khaleghian M, Divsalar K, Asgari E, Rezaei N.Chromosomal aberrations, sister chromatid exchanges and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs;Drug Chem Toxicol.
    2017 Apr; 40(2):235-240.
  6. Fallah F, Godarzi H, Lahoorpour F, Bandehpour M, Soleyman–Jahi S,
    Gachkar L. Molecular and Phenotypic Characteristics of Salmonella enterica Serovar Typhi Isolated from AsymptomaticCarrier.
    Infect Epidemiol Med 2016, 2 (3), 1-4
  7. Soleyman-JahiS,
    Zendehdel K, Abdirad A,
    Fallah AA, Ghasemi SSadeghi F, Tofighi S.
    Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: A Prospective study.
    Eur J Cancer 2016 Dec; 69:47
  8. Soleyman-Jahi S, Zendehdel K, Sadeghi F, Afshari Z, Barati T, Mohammadnezhad S, Ghasemi S, Amanpour S.
    Inhibitory effects of Aprotinin on local invasiveness of human breast adenocarcinoma cell lines.
    AACR 2017 April 1-5; accepted, in press (Proceeding of Annual Meeting of the American Association for Cancer Research).
  9. Soleyman-Jahi S, Yousefian A, Maheronnaghsh R, Shokraneh F, Zadegan SA, Soltani A, Hosseini SM, Vaccaro AR, Rahimi-Movaghar V. 
    Evidence-based Prevention and Treatment of Osteoporosis after Spinal Cord Injury: A Systematic Review.
    Eur Spine J. 2017 May 11. doi: 10.1007/s00586-017-5114-7 (Systematic review study)
  10. Majedi H, Dehghani SS, Soleyman-Jahi S, Emami Meibodi SA, Mireskandari SM, Hajiaghababaei M, Tafakhori A, Mendoza TR, CleelandCS .
    Validation of the Persian version of the Brief Pain Inventory (BPI-P) in chronic pain patients;
    J Pain Symptom Manage. 2017 May 4. pii: S0885-3924(17)30175-6. (Validation study of a trans-cultural questionnaire)
  11. Wahhabaghai H, Heidari R, Zeinoddini A, Soleyman-Jahi S,
    Golmanesh L, Rasoulian B, Akbari H, Foadoddoni M, Esmailidehaj M.
    Hyperoxia-induced preconditioning against renal ischemic injury is ROS-mediated but not related to heat shock proteins 70&32.
    Surgery 157.6 (2015): 1014-1022
  12. Shojaei A, Ramezanzadeh M,
    Soleyman-Jahi S
    ,
    Almasi-Nasrabadi M, Rezazadeh P, Eslani M.
    Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia.
    J Cataract Refract Surg. 2013;39(2):197-203 (Randomized Clinical Trial)
  13. Adib-Moghaddam S, Arba-Mosquera S, Walter-Fincke R, Soleyman-Jahi S,
    Adili-Aghdam F. Transepithelial Photorefractive Keratectomy for Hyperopia: A 12-Month Bi-central Study.
    J Refract Surg. 2016; 32:172-80. (A bi-central clinical study by Iran and Germany)
  14. Adib-Moghaddam S, Soleyman-Jahi S, Salmanian
    B, Omidvari AH, Adili-Aghdam F, Noorizadeh F, Eslani M.
    Single-Step Trans-Epithelial Photorefractive Keratectomy in Myopia and Astigmatism; 18-Month Follow up Results.
    J Cataract Refract Surg 2016 Nov; 42(11):1570-1578. Doi: 10.1016/j.jcrs.2016.08.029.
  15. Adib-Moghaddam S, Soleyman-Jahi S, Adili-Aghdam F, Arba-Mosquera S, Hoorshad N, Tofighi S.Single-step Transepithelial Photorefractive Keratectomy in Correction of High Myopia:  Qualitative and Quantitative Visual Functions.
    Int J Ophthalmol 2017 Mar 18;10(3):445-452
  16. Pishgar F, Soleyman-Jahi S,
    Pishgar F, Eftekhar Ardebili H, Jamal A, Arab AH.
    Level of happiness and its determining factors in pregnant women: a cross-sectional study;
    J Reproduct Infant Psychol 2016; 34 (5) 431-441
  17. Karimi H, Soleyman-Jahi S, Hafezi-Nejad N, Rahimi-Movaghar A, Amin-Esmaeili M, Sharifi V, Hajebi A, Saadat S, Akbari Sari A, Rahimi-Movaghar V.
    Direct and indirect costs of non-fatal road traffic injuries in Iran; a population-based study.
    Traffic Injury Prevent 2017 May 19;18(4):393-397
  18. Fadaei MR, Soleyman-jahi S, Ehsani
    AH, Mortazavi H, Nourmohammad-Pour. Studying laboratory changes of (Urea, Cr, ALT, AST, RBC, and WBC) after prescribing Rituximab for cure-resisting pemphigus patients at RAZI hospital.
    Philippine Scientist J, 2014, 12 (4), 34-42
  19. Adib-Moghaddam S, Eslani M, Soleyman-Jahi S.
    Determinant factors of achieving “supervision” after Refined Single-Step TransPRK.
    ASCRS ASOA 2017 (Proceeding of the American Society of Cataract and Refractive surgeons 2015).
  20. Adib-Moghaddam S, Soleyman-Jahi S,
    Adili-Aghdam F.
    Subjective Quality of Vision Outcomes of Transepithelial Photorefractive Keratectomy.ASCRS ASOA2015 (Proceeding of the American Society of Cataract and Refractive surgeons 2015).
  21. Adib-Moghaddam S, Soleyman-Jahi S, Adili-Aghdam F.
    Clinical Outcomes of Transepithelial Photorefractive Keratectomy in Hyperopia: Follow-up Study.
    ASCRS ASOA2014 (Proceeding of the American Society of Cataract and Refractive surgeons 2014).


Under Peer-Review/Revision



  1. Inhibitory effects of Aprotinin on local invasiveness of human breast adenocarcinoma cell lines. Under Review (First Author)
  2. Determinant Factors of pain management index in patients with chronic pain.
    Under Review
  3. Ciclesonide vs Fluticasone Propionate Nasal Sprays in Patients with Nasal Poplyposis; a Randomized Clinical Trial.
    ClinicalTrials.gov Identifier: NCT02665806. Under Review
  4. Hyperalgesia in patients with obstructive sleep hypopnea-apnea syndrome; interplay of inflammation and sleep disturbance;
    Under Reconsideration in Sleep (Corresponding Author)
  5. Determinant Factors of Quality of Vision after Transepithelial Photorefractive Keratectomy in patients with Myopia and Astigmatism. Under review
  6. Determinant Factors of orbital cyclotorsion in eyes undergoing Transepithelial Photorefractive Keratectomy. Under review
  7. Clinical outcomes of eyes with mild-moderate myopia undergoing Transepithelial Photorefractive Keratectomy with or without MMC. Under review
  8. Efficacy of a study skill course in knowledge, attitude and practice of medical students.Under Review (Corresponding Author)





Other main projects under execution



1-     **Inherited predisposition to gastrointestinal tumors with a focus on diffuse gastric cancer and adenomatous polyposis(an international multi-central study)


2-     **Prognostic Significance of p-53, MMP7, cox, VEGF in survival of gastric cancer: prospective survival study.


3-     **Prognostic Significance of Matrix Metalloproteinase-7 in Colorectal Cancer Survival: a meta-analysis.


4-     **Ghrelin role in cancer; A review study


5-     Trans-Epithelial Photorefractive Keratectomy; from beginning up to know. (A review Project.)


6-     Determinant Factors of achieving supervision in single-step refined trans-epithelial photorefractive keratectomy


Subjective quality of vision after single-step refined trans-epithelial photorefractive keratectomy; questionnaire-based study.



Innovations


I was a member of a team (TransPRK Research Group) who managed to develop:
(my Papers # 6,8)


“Refined method of laser-assisted refractive surgery (Refined TransPRK)”


“Refined post-operative medical regimen (Iran Regimen)”.



My Abstracts accepted in conferences:


1-           Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: Prospective Survival Study.
AACR, April 2016, New Orleans, USA


2-           Effect of mitomycin-C on the corneal endothelium following photorefractive keratectomy: a Randomized controlled clinical trial; ESCRS (in behalf of European society of cataract and refractive surgery) 2010, Paris,
France (Attended as oral lecturer)


3-           Contrast Sensitivity and Visual Outcomes after Transepithelial Photorefractive Keratectomy; ASCRS.ASOA symposium and congress, April 19-23 2013, San Francisco,
USA


4-           Visual, Contrast Sensitivity outcomes and Aberration changes after Trans-PRK in high myopia A 9-month follow-up study; The annual meeting of ISRS, Refractive Surgery Subspecialty day; April 2013; New Orleans,
USA


5-           Clinical outcomes of Transepithelial Photorefractive Keratectomy in Myopia 9 month follow up results; ESCRS XXXI, 5-9 October 2013, Amsterdam,
Netherlands


6-           Clinical Results Of Transepithelial Photorefractive Keratectomy in High Cylindrical Refraction Follow up Results; 18th ESCRS Winter Meeting, 14-16 February 2014,
Ljubljana


7-           Effect of trans-epithelial photorefractive keratectomy on myopic eyes visual quality and main factors predicting it; XXXII Congress of the ESCRS, 13-17 Sep. 2014, London,
UK


8-           Preoperative Visual Indices and Surgical Parameters That Influence Achieved Visual Acuity after TransPRK; AAO annual meeting, Oct. 17–18, 2014, Chicago, Illinois,
USA


9-           Comparison of patients with low and high preoperative corrected distance visual acuity undergoing trans-epithelial photorefractive keratectomy in terms of surgical outcomes; 19th ESCRS Winter Meeting, 20-22 February 2014, Istanbul, Turkey


10-        Subjective Quality of Vision Outcomes of Transepithelial Photorefractive Keratectomy; 2015 ASCRS ASOA Symposium and Congress, San Diego,
USA


11-        Effect of trans-epithelial photorefractive keratectomy on myopic eyes higher order aberrations and main factors predicting it; XXXIII Congress of the ESCRS, 5 - 9 Sept. 2015, Fira Gran Via, Barcelona,
Spain


12-        Hyperalgesia in patients with obstructive sleep hypopnea-apnea syndrome; interplay of inflammation and sleep disturbance. World Sleep Federation 2015, Istanbul, Turkey


13-        Clinical outcomes of eyes with mild-moderate myopia undergoing Transepithelial Photorefractive Keratectomy with or without MMC; XXXIV Congress of the ESCRS, 2016, Copenhagen,
Denmark


14-        Blue light and its physio-pathological effects; 13th Aegean Corneal Conference, Crete,
Greece, July 1-3, 2016. (Attended as oral lecturer)



I awarded following Research grants:



  1. One-month research observship programme in Hungary, 2013, IFMSA. This programme was held in a molecular and genetic study lab in
    Semmelweis University.
  2. One-month research observship programme in Czech Republic, 2014, IFMSA.
    This programme was held in a molecular and genetic cancer study lab in Charles University, Prague. 



Contributions and Positions



Invited Reviewer in following Peer-reviewed journals:



  1. Tumor Biology
  2. Journal of Cancer Research and Therapeutics
  3. Journal of Refractive Surgery
  4. Journal of ophthalmic and Vision Research
  5. BMC Ophthalmology


Lecturer and Director of Cancer Research Diploma, in Tehran University of Medical Sciences; some lecture topics include:



  1. Randomized Clinical Trials
  2. Systematic Review and Meta-analysis
  3. Evidence-based Medicine

Qualified as Active Member in the " American Association for Cancer Research", Philadelphia, USA


Qualified as a member of National Foundation of Elites

Managing Director of UCO interest group in USERN


Consultant in biostatistics and methodology:

1- Cancer Research Center, Cancer Institute of Iran, Tehran University of medical sciences, Tehran, Iran

2-Research center of Chronic Pain management, Tehran, Iran

3-TransPRK research Group, Bina Eye Hospital, Tehran, Iran



My Main Mentors:





  • Soheil Adib-Moghaddam, MD
  • Nima Rezaie, MD, PhD
  • Kazem Zendehdel, MD, PhD

  • Vafa Rahimi-Movaghar, MD







I have Skills and Experiences in:





  • Methodology

    • RCT, Cohort, Systematic Review and Meta-analysis

  • Biostatistics

    • Survival analysis
    • Meta-analysis
    • Approach to multivaraible model building
    • Questionnaire validity and reliability assessment

  • Laboratory techniques
  • Analysis Software 









No items yet!